Get startedLog in
    Picture of Klaria Pharma Holding AB (publ) logo

    KLAR — Klaria Pharma Holding AB (publ) News Story

    0.000.00%
    se flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapSucker Stock
    All News

    Brief: Klaria Pharma Regains Rights To Epinephrine Alginate Film From Purdue Canada and Mundipharma Network

    Picture of Klaria Pharma Holding AB (publ) logoKlaria Pharma Holding AB (publ)
    07/09/2020 17:47
    Sept 7 (Reuters) - Klaria Pharma Holding AB (publ)
 KLAR.ST :
    * KLARIA PHARMA REGAINS RIGHTS TO EPINEPHRINE ALGINATE FILM
AND
INITIATES CLINICAL DEVELOPMENT PROGRAM TO TREAT ANAPHYLAXIS
(SERIOUS ALLERGIC REACTIONS)
    * KLARIA PHARMA-DECIDED TO PROGRESS EPINEPHRINE ALGINATE
FILM INTO
CLINICAL DEVELOPMENT,GMP PRODUCTION ACTIVITIES OF PRODUCT HAVE
BEEN INITIATED

Source text for Eikon:  ID:nWkr9nvpPG 
Further company coverage:  KLAR.ST 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Klaria Pharma Holding AB (publ)

    See all news